Table 1 Demographic and clinical characteristics
From: Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies
CN (n = 148) | |
|---|---|
Age (years) | 68.93 ± 7.85 |
Education (years) | 11.67 ± 4.85 |
Gender, female (%) | 92 (62.2) |
CDR | 0 |
APOE ε4 allele(+) (%) | 25 (16.9) |
HRSD | 0.86 ± 1.60 |
VRS | 1.07 ± 0.92 |
Neuropsychological testsa | |
MMSE score | 26.94 ± 2.58 |
Animal fluency | 16.22 ± 4.70 |
Boston naming | 12.27 ± 2.37 |
Word list learning | 20.15 ± 4.15 |
Constructional praxis | 10.06 ± 1.37 |
Word list recall | 6.76 ± 1.83 |
Word list recognition | 9.24 ± 1.04 |
Constructional recall | 7.46 ± 2.80 |
Global amyloid burden (SUVR) | 1.16 ± 0.23 |
Amyloid positivity (%) | 16 (10.8) |
T3 (mg/dl) | 103.84 ± 17.34 |
Free T3 (pg/ml) | 3.11 ± 0.34 |
Free T4 (ng/dl) | 1.17 ± 0.16 |
TSH (μIU/ml) | 2.36 ± 1.57 |